Tuberculosis

Optimizing excess to bridge the gap for Tb treatment.

Tuberculosis (TB) is a leading cause of morbidity and mortality globally with an estimated 9 million cases and 1.5 million deaths each year. Health systems, health care staff and public health professionals in high TB burden settings face particular challenges in tackling this complex disease that is driven by societal, social, economic and medical factors. In low burden settings, TB has become relatively uncommon with the disease concentrated in marginalized and vulnerable groups with the associated challenges of early diagnosis, curtailing transmission and supporting complex patients to complete the long course of treatment. Antimicrobial resistance, in the form of multidrug-resistant TB, poses a particular challenge to disease control and has recently been declared a crisis by the WHO. To increase awareness, World TB Day takes place on March 24th every year. Despite recent advances, TB remains one of the world’s deadliest diseases. TB incidence worldwide has declined 18 percent since 2000. However, in 2014 the disease still caused 9.6 million people across the globe to be sick, and killed 1.5 million people, mainly in developing countries, according to the WHO. TB is also a leading cause of death in people with HIV/AIDS: in 2015, one in three deaths among HIV-infected individuals worldwide was due to TB. Although most TB is curable, certain forms of the bacterium that causes TB are becoming resistant to the drugs designed to kill them. Patient adherence to therapy was already difficult as most regimens require taking medicine daily for six months to two years. The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB has caused significant setbacks in the effort to effectively treat and cure patients, and highlights the need for new medicines.

PAKISTAN SITUATION:

Pakistan is currently ranked among 20 high disease burden countries with 500,000 cases per year in 2015. Pakistan’s National TB Program has developed public-private mix (PPM) models for TB care. They center on the engagement of different actors, such as NGOs, public and private hospitals, private practitioners, laboratories and pharmacies. The NTP and its partners have also established a successful PPM model for the management of drug-resistant TB based in public and private tertiary hospitals. Good outcomes have been demonstrated by numerous PPM providers in the quality of diagnosis, treatment and patient support for patients with TB and drug-resistant TB.

Global Fund Round 8. TB drug management Project .

Principal Receipient -Green Star Social Marketing Pvt. Pakistan Lions Youth Council implemented the project in 3 Districts of Punjab to Reduce morbidity and mortality due to TB through Human resources development: Training providers in -TB drug management Through this project PLYC conducted the trainings of Doctors, paramedics and store keepers on Drug Management target Districts. PLYC trained 541 Public Sector Doctors and 1014 Public Sector Paramedics Training on TB Drug Management, 221 Public Sector Doctors Refresher Training on TB DM, 520 Public Sector Paramedics Refresher Training on TB DM, 126 Private Sector Doctors Training on TB DM, 108 Private Sector Paramedics Training on TB DM, 48 Private Sector Doctors Refresher on TB DM, 165 Public Sector Training on DMIS.

Global Fund Round 9 (Public Private Mix)

Pakistan Lions Youth Council is implementing the project to offer quality care to TB Patients through PPM( Public Private Mix), with support of Global Fund/Mercy Corps To Enable a network of private sector & Parastatal Hospital.and to reduce TB Burden In Pakistan by improving access to quality DOTS & MDR TB care services in-Multan-DGKhan-Rajanp Lodhran, Khanewal Vehari Pakpattan Sahiwal in Punjab and Gotki , Shikarpur, jacbabad and Kashmore in Sindh and Parastatal Hospitals of Social Security and Ralway were Multan, Sialkot ,Gujranwala,Gujrat Shekhupura


Number of of notified TB cases, all forms diagnosed and registered-5584
  • Bacteriologically confimred TB, New and relapse cases diagnosed and registered-1715.
  • Bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases -895.
  • Successfully treated amongst the bacteriologically confirmed TB cases diagosed in the corresponding quarter one year before-895
  • Registered bacteriologically confirmed TB patients (N+R) whose contacts were screened 1483.
  • Private health facilities/GPs implementing DOTS as per National Guidelines- 164
  • PARAMEDICS received REFRESHER training 164
  • TB cases registered through chest camps- 256